Chemotherapy-induced peripheral neuropathy in breast cancer patients treated with eribulin: interim data from a post-marketing observational study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1880-4233
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Chemotherapy-induced peripheral neuropathy in breast cancer patients treated with eribulin: interim data from a post-marketing observational study ; day:15 ; month:10 ; year:2018 ; pages:1-9
Breast cancer ; (15.10.2018), 1-9
- Creator
-
Tsurutani, Junji
- Contributor
-
Sakata, Yukinori
Matsuoka, Toshiyuki
SpringerLink (Online service)
- DOI
-
10.1007/s12282-018-0919-8
- URN
-
urn:nbn:de:101:1-2018112020041934074538
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tsurutani, Junji
- Sakata, Yukinori
- Matsuoka, Toshiyuki
- SpringerLink (Online service)
Other Objects (12)
Informative gene network for chemotherapy-induced peripheral neuropathy
Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials
Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control
Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients
Type of exercise may influence postural adaptations in chemotherapy‐induced peripheral neuropathy
Modulation of tissue specific membrane transporters for prevention of chemotherapy-induced peripheral neuropathy
Initial observations on sexual dysfunction as a symptom of chemotherapy-induced peripheral neuropathy
Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy
Effect of Menopausal Status on Chemotherapy-Induced Peripheral Neuropathy: Single-Institution Retrospective Audit
A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy
GSTM1 and GSTT1 polymorphisms associated with pain in a chemotherapy-induced peripheral neuropathy cohort
Informative gene network for chemotherapy-induced peripheral neuropathy
Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials
Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control
Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients
Type of exercise may influence postural adaptations in chemotherapy‐induced peripheral neuropathy
Modulation of tissue specific membrane transporters for prevention of chemotherapy-induced peripheral neuropathy
Initial observations on sexual dysfunction as a symptom of chemotherapy-induced peripheral neuropathy
Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy
Effect of Menopausal Status on Chemotherapy-Induced Peripheral Neuropathy: Single-Institution Retrospective Audit
A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy
GSTM1 and GSTT1 polymorphisms associated with pain in a chemotherapy-induced peripheral neuropathy cohort
Informative gene network for chemotherapy-induced peripheral neuropathy
Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials
Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control
Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients
Type of exercise may influence postural adaptations in chemotherapy‐induced peripheral neuropathy
Modulation of tissue specific membrane transporters for prevention of chemotherapy-induced peripheral neuropathy
Initial observations on sexual dysfunction as a symptom of chemotherapy-induced peripheral neuropathy
Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy
Effect of Menopausal Status on Chemotherapy-Induced Peripheral Neuropathy: Single-Institution Retrospective Audit
A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy